§ BIOTECHNOLOGY
USD · BiotechnologyXENE
XENON PHARMACEUTICALS INC
USDSector · BiotechnologyBeta · 0.65
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
179 increased/new, 97 decreased/exited (13F)
AC 13F Analysis
§ 04 · FUNDAMENTALS · THE BOOKS
| P/B | 6.09 | EPS (TTM) | -4.36 |
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| Fidelity Management | 10.8M | 0.0% | +21% |
| Avoro Capital Advisors LLC | 5.8M | 3.3% | n/a |
| BlackRock, Inc. | 5.6M | 0.0% | +11% |
| WELLINGTON MANAGEMENT GROUP LLP | 4.8M | 0.1% | +1% |
| Driehaus Capital Management LLC | 4.5M | 1.9% | −1% |
| Polar Capital Holdings Plc | 4.4M | 0.9% | +79% |
◇ AC INTELLIGENCE
Top institutional owners for XENE as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER98.0% · 0 holders
OTHER1.0% · 203 holders
QUALITY / COMPOUNDER0.6% · 28 holders
DEALER / BANK0.1% · 28 holders
PASSIVE / INDEX0.1% · 10 holders
TACTICAL / MACRO0.1% · 6 holders
SYSTEMATIC / QUANT0.0% · 5 holders
INCOME / DEFENSIVE0.0% · 16 holders
ACTIVIST0.0% · 1 holder
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for XENE in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention XENE yet.